share_log

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

周三盘后交易时段,12只医疗保健类股走势
Benzinga ·  2023/08/09 14:32

Gainers

获胜者

  • Vistagen Therapeutics (NASDAQ:VTGN) stock rose 22.5% to $8.62 during Wednesday's after-market session. Trading volume for this security closed at 4.6 million, accounting for 394.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $68.8 million.
  • AIM ImmunoTech (AMEX:AIM) shares rose 11.69% to $0.64. The market value of their outstanding shares is at $30.7 million.
  • Tenon Medical (NASDAQ:TNON) shares moved upwards by 10.45% to $0.26. Tenon Medical's trading volume hit 156.5K shares by close, accounting for 23.3% of its average volume over the last 100 days. The company's market cap stands at $5.6 million. The company's, Q2 earnings came out yesterday.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 10.19% to $0.95. The market value of their outstanding shares is at $11.1 million.
  • PMV Pharma (NASDAQ:PMVP) stock increased by 10.13% to $9.55. The market value of their outstanding shares is at $437.1 million. As per the news, the Q2 earnings report came out today.
  • LogicMark (NASDAQ:LGMK) shares moved upwards by 9.31% to $2.7. The market value of their outstanding shares is at $3.4 million.
  • 维斯塔根 Therapeutics 纳斯达克股票代码:VTGN)股价在周三的盘后交易时段上涨了22.5%,至8.62美元。该证券的交易量收于460万只,占其过去100天平均全日交易量的394.0%。他们已发行股票的市值为6,880万美元。
  • AIM 免疫科技 (AMEX: AIM) 股价上涨11.69%,至0.64美元。他们已发行股票的市值为3,070万美元。
  • 泰农医疗 纳斯达克股票代码:TNON)股价上涨10.45%,至0.26美元。收盘时,Tenon Medical的交易量达到15.65万股,占其过去100天平均成交量的23.3%。该公司的市值为560万美元。该公司第二季度财报于昨天公布。
  • Virpax 制药 纳斯达克股票代码:VRPX)的股价上涨了10.19%,至0.95美元。他们已发行股票的市值为1,110万美元。
  • PMV 制药 纳斯达克股票代码:PMVP)的股票上涨了10.13%,至9.55美元。他们已发行股票的市值为4.371亿美元。根据消息,第二季度财报于今天发布。
  • LogicMark 纳斯达克股票代码:LGMK)股价上涨9.31%,至2.7美元。他们已发行股票的市值为340万美元。

Losers

失败者

  • Galera Therapeutics (NASDAQ:GRTX) stock declined by 83.2% to $0.38 during Wednesday's after-market session. Trading volume for this security closed at 8.6 million, accounting for 1034.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.1 million.
  • Organogenesis Hldgs (NASDAQ:ORGO) stock fell 41.0% to $2.0. At the close, Organogenesis Hldgs's trading volume reached 194.3K shares. This is 17.7% of its average volume over the last 100 days. The company's market cap stands at $262.5 million. As per the press release, Q2 earnings came out today.
  • Matinas BioPharma Hldgs (AMEX:MTNB) shares declined by 15.16% to $0.28. Today's trading volume for this security ended up closing at 153.6K shares, which is 32.0 percent of its average volume over the last 100 days. The company's market cap stands at $61.6 million. The company's, Q2 earnings came out today.
  • Infinity Pharmaceuticals (NASDAQ:INFI) shares decreased by 12.4% to $0.1. Infinity Pharmaceuticals's trading volume hit 2.3 million shares by close, accounting for 86.5% of its average volume over the last 100 days. The company's market cap stands at $9.0 million.
  • Akso Health Group (NASDAQ:AHG) shares declined by 11.88% to $0.32. The market value of their outstanding shares is at $7.3 million.
  • Aceragen (NASDAQ:ACGN) shares declined by 9.3% to $0.53. The company's market cap stands at $4.4 million. See Also:
  • Galera Therape 纳斯达克股票代码:GRTX)股价在周三的盘后交易时段下跌了83.2%,至0.38美元。该证券的交易量收于860万只,占其过去100天平均全日交易量的1034.8%。他们已发行股票的市值为1,610万美元。
  • Organogenesis Hold 纳斯达克股票代码:ORGO)股价下跌41.0%,至2.0美元。收盘时,Organogenesis Hldgs的交易量达到19.43万股。这是过去100天平均交易量的17.7%。该公司的市值为2.625亿美元。根据新闻稿,第二季度财报于今天公布。
  • 马蒂纳斯生物制药控股公司 (AMEX: MTNB) 股价下跌15.16%,至0.28美元。该证券今天的交易量最终收于153.6万股,占其过去100天平均交易量的32.0%。该公司的市值为6160万美元。该公司第二季度财报于今天公布。
  • 无限制药 纳斯达克股票代码:INFI)股价下跌12.4%,至0.1美元。截至收盘,Infinity Pharmicals的交易量达到230万股,占其过去100天平均交易量的86.5%。该公司的市值为900万美元。
  • Akso 健康集团 纳斯达克股票代码:AHG)股价下跌11.88%,至0.32美元。他们已发行股票的市值为730万美元。
  • Aceragen 纳斯达克股票代码:ACGN)股价下跌9.3%,至0.53美元。该公司的市值为440万美元。 另请参阅:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成,并由编辑审阅。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发